Michael Terence Publishing is excited to announce the release of “A Very Romantic Story About No Romance: The Love Story of The Blues” � a depression and anxiety self-help guide by Flower G.
Depression and Anxiety. Anger and Guilt. Loss and Fear. Inner Darkness and Demons. The Blues.
They are the dark side of Humanity and Life. And they are totally normal. What shouldn’t be normal is our reaction to the Darkness.
No matter if you are a victim or a witness of depression, or you are just curious about life this book is an encouraging self-help guide/collision between life experience, fiction and non-fiction written for the courageous ones of all ages who are seeking change.
This book takes the reader on a journey of self-reflection and lessons of self-love with its inspirational short stories.
A Very Romantic Story About No Romance: The Love Story of The Blues is available in multiple formats worldwide:
Paperback: 280 pages
ISBN-13: 9781913653477 and 9781913653385
Dimensions: 12.1 x 1.6 x 19.8 cm
Amazon Kindle eBook: B0893DHWC9
Amazon URL: http://getbook.at/VRS
Published by Michael Terence Publishing, 2020
About Michael Terence Publishing
Web: www.mtp.agency
Michael Terence Publishing is a UK-based hybrid publishing house and literary agency founded to give worthy authors a platform to publish their works and to promote their success via online and traditional channels.
For further information, media packs and interview requests please contact:
Michael Terence Publishing
Marketing & Promotions
Two Brewers House
2A Wellington Street
Thame
Oxfordshire OX9 3BN
UK
Email: admin@mtp.agency
Web: www.mtp.agency
Tel: +44 (0)20 3582 2002
Let’s block ads! (Why?)
SINGAPORE - Media OutReach Newswire - 29 April 2024 - From 26 April to 12…
SINGAPORE - Media OutReach Newswire - 29 April 2024 - XT, the world's first socially…
LONDON--(BUSINESS WIRE)--#BonteFriedheim--NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector,…
H2SITE’s AMMONIA to H2POWER technology for ammonia cracking on-board has received Approval in Principle (AiP)…
Daiichi Sankyo and AstraZeneca’s ENHERTU also demonstrated a clinically meaningful progression-free survival improvement in patients…
Q1 2024 Group sales at $7.4 billion, -20% (-18% at CER) versus prior year Q1…